Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples